We are live on
!
Find out more
OI
Oakbrook Investments Portfolio holdings
AUM
$39.2M
Turnover
87.07%
1-Year Est. Return
3.66%
This Fund
S&P 500
This Quarter
Est. Return
-11.13%
1 Year Est. Return
-3.66%
3 Year Est. Return
+26.09%
5 Year Est. Return
+53.43%
10 Year Est. Return
–
AUM
$1.47B
AUM Growth
-$329M
(-18%)
Cap. Flow
-$115M
Cap. Flow
% of AUM
-7.78%
Top 10 Holdings %
Top 10 Hldgs %
25.26%
Holding
689
New
51
Increased
102
Reduced
416
Closed
118
Avg Time Held
2.4
years
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mondelez International
MDLZ
|
+$15.6M |
| 2 |
3M
MMM
|
+$6.69M |
| 3 |
SLB Ltd
SLB
|
+$6.53M |
| 4 |
Coca-Cola
KO
|
+$5.62M |
| 5 |
Intel
INTC
|
+$5.37M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$19.3M |
| 2 |
McCormick & Company Non-Voting
MKC
|
+$17.5M |
| 3 |
Merck
MRK
|
+$5.64M |
| 4 |
Verizon
VZ
|
+$5.1M |
| 5 |
RTN
Raytheon Company
RTN
|
+$4.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.8% |
| 2 | Technology | 15.36% |
| 3 | Financials | 14.99% |
| 4 | Consumer Discretionary | 11.33% |
| 5 | Consumer Staples | 10.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$4.99T
| $46.5M | 3.15% |
1,178,104
+51,600
| +5% | +$2.5M |
2013 Q2
22 quarters
|
|
2
CME Group
CME
$104B
| $39M | 2.64% |
207,050
-1,515
| -0.7% | -$280K |
2013 Q2
22 quarters
|
|
|
3
Merck
MRK
$358B
| $37.2M | 2.53% |
510,528
-79,914
| -14% | -$5.64M |
2013 Q2
22 quarters
|
|
4
Nike
NKE
$55.2B
| $37.1M | 2.52% |
500,485
-18,275
| -4% | -$1.37M |
2013 Q2
22 quarters
|
|
5
Walt Disney
DIS
$191B
| $36.3M | 2.46% |
331,185
-7,505
| -2% | -$853K |
2013 Q2
22 quarters
|
|
6
Medtronic
MDT
$122B
| $36.3M | 2.46% |
399,185
-25,950
| -6% | -$2.42M |
2013 Q2
22 quarters
|
|
7
Visa
V
$750B
| $35.8M | 2.43% |
271,063
-3,035
| -1% | -$419K |
2013 Q2
22 quarters
|
|
8
PepsiCo
PEP
$175B
| $35.5M | 2.41% |
321,411
+47,435
| +17% | +$5.35M |
2013 Q2
22 quarters
|
|
9
Starbucks
SBUX
$110B
| $35.5M | 2.41% |
550,595
-57,670
| -9% | -$3.61M |
2015 Q1
15 quarters
|
|
10
Amgen
AMGN
$235B
| $33.2M | 2.25% |
170,306
-1,120
| -0.7% | -$219K |
2013 Q2
22 quarters
|
|
|
VAR
11
DELISTED
Varian Medical Systems, Inc.
VAR
| $31.7M | 2.15% |
279,736
-1,460
| -0.5% | -$167K |
2016 Q2
10 quarters
|
|
12
Caterpillar
CAT
$338B
| $31M | 2.1% |
243,998
-15,800
| -6% | -$2.06M |
2013 Q2
22 quarters
|
|
|
13
Mondelez International
MDLZ
$80.4B
| $30.3M | 2.06% |
757,456
+367,071
| +94% | +$15.6M |
2013 Q2
22 quarters
|
|
|
14
3M
MMM
$85.3B
| $30.3M | 2.05% |
190,019
+40,287
| +27% | +$6.69M |
2013 Q2
22 quarters
|
|
15
Autodesk
ADSK
$51.2B
| $30.1M | 2.04% |
233,989
-24,320
| -9% | -$3.28M |
2013 Q2
22 quarters
|
|
16
Microsoft
MSFT
$4.01T
| $30M | 2.03% |
295,122
-12,500
| -4% | -$1.34M |
2013 Q2
22 quarters
|
|
17
Alphabet (Google) Class A
GOOGL
$4.27T
| $29.1M | 1.97% |
556,040
-24,160
| -4% | -$1.31M |
2015 Q4
12 quarters
|
|
18
Amazon
AMZN
$2.75T
| $24M | 1.63% |
320,080
-18,500
| -5% | -$1.54M |
2013 Q2
22 quarters
|
|
19
Alphabet (Google) Class C
GOOG
$4.22T
| $23.6M | 1.6% |
455,800
+62,880
| +16% | +$3.37M |
2013 Q2
22 quarters
|
|
20
Colgate-Palmolive
CL
$73.9B
| $23.5M | 1.59% |
394,449
+48,540
| +14% | +$3.04M |
2018 Q3
1 quarter
|
|
21
Biogen
BIIB
$34.8B
| $18.3M | 1.24% |
60,940
+11,635
| +24% | +$3.71M |
2013 Q2
22 quarters
|
|
|
22
McCormick & Company Non-Voting
MKC
$12.3B
| $17.5M | 1.18% |
250,654
-244,064
| -49% | -$17.5M |
2014 Q1
19 quarters
|
|
|
23
SLB Ltd
SLB
$71.8B
| $17.3M | 1.17% |
479,764
+132,290
| +38% | +$6.53M |
2013 Q2
22 quarters
|
|
24
Qualcomm
QCOM
$191B
| $15.4M | 1.04% |
270,378
-72,928
| -21% | -$4.43M |
2013 Q2
22 quarters
|
|
25
Meta Platforms (Facebook)
META
$1.88T
| $13.8M | 0.93% |
105,092
-1,550
| -1% | -$225K |
2013 Q2
22 quarters
|
|
Similar funds
MF
AIM
QCMA
SC
BIM
GP
GAM
SCM
Oakbrook Investments's Q4 2018 Portfolio in Review
As of Q4 2018, Oakbrook Investments held 689 positions worth $1.47B, down 18% from $1.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Oakbrook Investments withdrew a net $115M in Q4 2018, closing 118 positions and reducing 416 holdings. Its most notable exit was Johnson Controls International, an estimated $19.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Technology and Financials.
Against the trend, Oakbrook Investments opened a new position in Cognizant worth $2.98M.
- Oakbrook Investments's largest Q4 2018 buy was Cognizant: 47,020 shares worth $2.98M.
- Oakbrook Investments added most to Mondelez International in Q4 2018, an estimated $15.6M increase.
- Oakbrook Investments's biggest Q4 2018 reduction was McCormick & Company Non-Voting, cutting an estimated $17.5M.
- Oakbrook Investments fully exited Johnson Controls International in Q4 2018, selling an estimated $19.3M.
- Oakbrook Investments's ten largest holdings make up 25% of its $1.47B portfolio in Q4 2018.
- Oakbrook Investments opened 51 new positions and closed 118 in Q4 2018.
- Oakbrook Investments's portfolio value fell 18% quarter-over-quarter to $1.47B.
Based on Oakbrook Investments's 13F filing for Q4 2018, filed 17 Jan 2019.